AI
Wednesday, September 26, 2018 11:42:52 AM
it's newest FDA approval product Zolpimist, just been added a month ago hence will be represented in upcoming earning and beyond. see last Paragraph (above) includes market potential:
market potential:
strong Pipeline/ Catalysts:
2019 will be a huge year for this Company per both CEO and analysts. sales and revenues boost (yahoo Finance):
* Sales Growth 2019 by analyst coverage: 255.20%
* Revenue Estimate 2019 $13M
fits CEO's comments recently.
These block baster FDA approved drugs worth a lot more than a few millions market cap, that's for sure. Now can seat down and wait big data in a few weeks and a good chance it will be great like the previous one (and strong pipeline in 2019 too).
I expect a massive upside the coming weeks.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Recent AYTU News
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
